A radiogenomics application for prognostic profiling of endometrial cancer.

3b ; p = 0.0006) and the poor prognostic impact of the high signature score was reproduced in the EC cohort with full L1000 gene expression data ( n = 392) (Table 3 , all clinico-pathological variables highly significant; Fig. 3c , p < 0.0001).

also in 132,142 other papers